Imricor Medical Systems (ASX:IMR) said Semmelweis University's Heart and Vascular Center in Hungary performed its first atrial flutter ablations guided by real-time magnetic resonance imaging, through the company's NorthStar 3D mapping system, according to a Thursday filing with the Australian bourse.
The company aims for continued expansion and growth across Europe, including adding more sites to the VISABL-VT clinical trial, the filing said.
Imricor Medical Systems shares rose past 2% in morning trade Thursday.
Price (AUD): $1.66, Change: $+0.040, Percent Change: +2.47%